U.S. regulators have authorized a fourth dose of Pfizer-BioNTech's COVID-19 vaccine for Americans 50 and older because of concerns about waning immunity in the age group, the drugmakers said on Tuesday.
source https://www.cbc.ca/news/health/fourth-dose-covic-vaccine-pfizer-1.6401036?cmp=rss
No comments:
Post a Comment